- Presentations
- 6
- Markets
- 1
Mounjaro KwikPen is a brand of Tirzepatide marketed by Eli Lilly, with 6 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Tirzepatide
- Brand owner
- Eli Lilly
- Registered in
- United States
- Strengths and forms
- 10.008 mg/2.4 mL injection, 19.992 mg/2.4 mL injection, 30 mg/2.4 mL injection, 40.08 mg/2.4 mL injection, 49.92 mg/2.4 mL injection, 60 mg/2.4 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Mounjaro KwikPen 10.008 mg/2.4 mL injectionSubcutaneous Cold chain | Eli Lilly | US FDA | Available on request |
| Mounjaro KwikPen 19.992 mg/2.4 mL injectionSubcutaneous Cold chain | Eli Lilly | US FDA | Available on request |
| Mounjaro KwikPen 30 mg/2.4 mL injectionSubcutaneous Cold chain | Eli Lilly | US FDA | Available on request |
| Mounjaro KwikPen 40.08 mg/2.4 mL injectionSubcutaneous Cold chain | Eli Lilly | US FDA | Available on request |
| Mounjaro KwikPen 49.92 mg/2.4 mL injectionSubcutaneous Cold chain | Eli Lilly | US FDA | Available on request |
| Mounjaro KwikPen 60 mg/2.4 mL injectionSubcutaneous Cold chain | Eli Lilly | US FDA | Available on request |
Equivalent brands
Other brands of Tirzepatide.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Mounjaro KwikPen
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.